Literature DB >> 23748046

The rate of spontaneous mutations in human myeloid cells.

David J Araten1, Ondrej Krejci, Kimberly Ditata, Mark Wunderlich, Katie J Sanders, Leah Zamechek, James C Mulloy.   

Abstract

The mutation rate (μ) is likely to be a key parameter in leukemogenesis, but historically, it has been difficult to measure in humans. The PIG-A gene has some advantages for the detection of spontaneous mutations because it is X-linked, and therefore only one mutation is required to disrupt its function. Furthermore, the PIG-A-null phenotype is readily detected by flow cytometry. Using PIG-A, we have now provided the first in vitro measurement of μ in myeloid cells, using cultures of CD34+ cells that are transduced with either the AML-ETO or the MLL-AF9 fusion genes and expanded with cytokines. For the AML-ETO cultures, the median μ value was ∼9.4×10(-7) (range ∼3.6-23×10(-7)) per cell division. In contrast, few spontaneous mutations were observed in the MLL-AF9 cultures. Knockdown of p53 or introduction of mutant NRAS or FLT3 alleles did not have much of an effect on μ. Based on these data, we provide a model to predict whether hypermutability must occur in the process of leukemogenesis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AML; B-lymphoblastoid cell lines; BLCLs; GPI; GPI-linked proteins; Human myeloid cultures; Mutation rate; Myeloid leukemia.; PIG-A gene; PNH; Spontaneous somatic mutations; acute myelogenous leukemia; glycosylphosphatidylinositol; paroxysmal nocturnal hemoglobinuria

Mesh:

Substances:

Year:  2013        PMID: 23748046      PMCID: PMC4524336          DOI: 10.1016/j.mrfmmm.2013.05.004

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  74 in total

1.  Evidence for mutation showers.

Authors:  Jicheng Wang; Kelly D Gonzalez; William A Scaringe; Kimberly Tsai; Ning Liu; Dongqing Gu; Wenyan Li; Kathleen A Hill; Steve S Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

2.  The effect of p53-RNAi and p53 knockout on human 8-oxoguanine DNA glycosylase (hOgg1) activity.

Authors:  Aditi Chatterjee; Elizabeth Mambo; Motonobu Osada; Sunil Upadhyay; David Sidransky
Journal:  FASEB J       Date:  2005-11-17       Impact factor: 5.191

3.  The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7.

Authors:  Trisha M Wise-Draper; Hillary V Allen; Megan N Thobe; Elizabeth E Jones; Kristen B Habash; Karl Münger; Susanne I Wells
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  A quantitative measurement of the human somatic mutation rate.

Authors:  David J Araten; David W Golde; Rong H Zhang; Howard T Thaler; Lucia Gargiulo; Rosario Notaro; Lucio Luzzatto
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

5.  The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.

Authors:  M A Christophorou; I Ringshausen; A J Finch; L Brown Swigart; G I Evan
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

6.  A network of genetic events sufficient to convert normal human cells to a tumorigenic state.

Authors:  S DiSean Kendall; Corinne M Linardic; Stacey J Adam; Christopher M Counter
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  David J Araten; Lucio Luzzatto
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

8.  BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance.

Authors:  Mateusz Koptyra; Rafal Falinski; Michal O Nowicki; Tomasz Stoklosa; Ireneusz Majsterek; Margaret Nieborowska-Skorska; Janusz Blasiak; Tomasz Skorski
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

9.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Salil Goorha; Ina Radtke; Christopher B Miller; Elaine Coustan-Smith; James D Dalton; Kevin Girtman; Susan Mathew; Jing Ma; Stanley B Pounds; Xiaoping Su; Ching-Hon Pui; Mary V Relling; William E Evans; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2007-04-12       Impact factor: 49.962

10.  Allometric scaling of the active hematopoietic stem cell pool across mammals.

Authors:  David Dingli; Jorge M Pacheco
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  5 in total

1.  Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk+/- cells and the CD90.2 antigen.

Authors:  Jeffrey C Bemis; Svetlana L Avlasevich; Carson Labash; Page McKinzie; Javier Revollo; Vasily N Dobrovolsky; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2017-11-08       Impact factor: 3.216

2.  The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype.

Authors:  V J Forster; M H Nahari; N Martinez-Soria; A K Bradburn; A Ptasinska; S A Assi; S E Fordham; H McNeil; C Bonifer; O Heidenreich; J M Allan
Journal:  Leukemia       Date:  2015-06-08       Impact factor: 11.528

3.  Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis.

Authors:  P Savola; T Kelkka; H L Rajala; A Kuuliala; K Kuuliala; S Eldfors; P Ellonen; S Lagström; M Lepistö; T Hannunen; E I Andersson; R K Khajuria; T Jaatinen; R Koivuniemi; H Repo; J Saarela; K Porkka; M Leirisalo-Repo; S Mustjoki
Journal:  Nat Commun       Date:  2017-06-21       Impact factor: 14.919

Review 4.  Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.

Authors:  M Craig
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-04-18

5.  MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.

Authors:  Nikki A Evensen; P Pallavi Madhusoodhan; Julia Meyer; Jason Saliba; Ashfiyah Chowdhury; David J Araten; Jacob Nersting; Teena Bhatla; Tiffaney L Vincent; David Teachey; Stephen P Hunger; Jun Yang; Kjeld Schmiegelow; William L Carroll
Journal:  Haematologica       Date:  2018-02-15       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.